The Archer® FusionPlex® Comprehensive Thyroid & Lung (CTL) Kit is a targeted NGS panel to detect gene fusions, SNV, indels, splicing and gene expression in 36 genes associated with lung and thyroid cancers. This panel complements the Archer VariantPlex® CTL Panel for comprehensive mutation profiling of fusions, CNVs and variants.
Studies are performed from RNA extracted from several types of starting sample. Using Archer’s proprietary Anchored Multiplex PCR (AMP™)-based enrichment, fusions of all genes in this kit can be identified in a single sequencing assay, even without prior knowledge of fusion partners or breakpoints.
Archer Analysis software allows the analysis and interpretation of the data.
Archer® FusionPlex® Lung
The Archer® FusionPlex® Lung Kit is focussed to detect EGFR vIII and MET exon 14 skipping events along with prominent ALK, BRAF, FGFR, NRG1, NTRK, RET, and ROS1 fusions and select point mutations in 14 key gene targets associated with lung cancer.
|Archer® FusionPlex® Comprehensive Thyroid & Lung (CTL)|
|Archer® FusionPlex® Lung|